Bioquell PLC Trading Statement (2789B)

TIDMBQE

RNS Number : 2789B

Bioquell PLC

09 January 2018

9 January, 2018

Bioquell PLC

Trading statement

Bioquell PLC ("Bioquell") (LSE symbol: BQE) - a leading provider of specialist biodecontamination products and services for the international Life Sciences, pharmaceutical and healthcare markets today announces an update on its trading performance prior to entering the closed period ahead of the preliminary results for the year to 31 December 2017.

We estimate that revenues for the year ended 31 December, 2017 will be ahead of our previous expectations at approximately GBP29.3 million (2016: GBP26.8 million)

This estimate comprises GBP28.6m for the biodecontamination business (2016: GBP25.2m), representing growth of some 13% (9.6% at constant currency rates) and GBP0.7m for the defence business (2016: GBP1.3m), where revenues fluctuate significantly from year to year.

Pre-exceptional earnings before tax are expected to be significantly ahead of market expectations. As previously announced, an exceptional gain of GBP0.25m will be recognised on the disposal of the Airflow business.

The Company had net cash of GBP14.5m at the year end.

The preliminary results for the year ended 31 December, 2017 will be announced on 7 March, 2018.

- Ends -

Enquiries

   Bioquell PLC           01264 835900 
   Ian Johnson                  Executive Chairman 
   Michael Roller              Finance Director 

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTEAXFPEFFPEFF

(END) Dow Jones Newswires

January 09, 2018 02:00 ET (07:00 GMT)